Sniderman Allan D, Marcovina Santica M
Mike Rosenbloom Laboratory for Cardiovascular Research, Room H7.22, McGill University Health Centre, 687 Pine Avenue West, Montreal, Quebec H3A 1A1, Canada.
Clin Lab Med. 2006 Dec;26(4):733-50. doi: 10.1016/j.cll.2006.07.007.
This article reviews the evidence showing that apolipoprotein (apo) B and A-1 are superior to the conventional cholesterol indices as analytes in laboratory practice, indices of the lipoprotein-related risk for vascular disease, and measures of the adequacy of low-density lipoprotein-lowering therapy.
本文回顾了相关证据，这些证据表明，在实验室实践中，载脂蛋白（apo）B和A-1作为分析物、作为血管疾病脂蛋白相关风险指标以及作为低密度脂蛋白降低治疗充分性的衡量指标，优于传统的胆固醇指标。
